74 related articles for article (PubMed ID: 14679675)
1. [Evaluation of drug cost reduction resulting from the free supply of investigational drugs].
Corvaisier S; Ferry S; Rochefort F
Therapie; 2003; 58(4):353-60. PubMed ID: 14679675
[TBL] [Abstract][Full Text] [Related]
2. Costs and savings of investigational drug services.
McDonagh MS; Miller SA; Naden E
Am J Health Syst Pharm; 2000 Jan; 57(1):40-3. PubMed ID: 10630555
[TBL] [Abstract][Full Text] [Related]
3. Retrospective pharmaceutical financial benefits and cost avoidance analysis of clinical trial participation in the Australian haematology setting.
Truong K; Kwan YL; Nigro L; Huseincehajic A; Trotman J
Intern Med J; 2019 Sep; 49(9):1092-1098. PubMed ID: 30907047
[TBL] [Abstract][Full Text] [Related]
4. Drug Cost Avoidance in Prostate Cancer Clinical Trials.
Calvin-Lamas M; Portela-Pereira P; Rabuñal-Alvarez MT; Martinez-Breijo S; Martín-Herranz MI; Gómez-Veiga F
Actas Urol Esp; 2015 Nov; 39(9):553-7. PubMed ID: 26071987
[TBL] [Abstract][Full Text] [Related]
5. Drug cost avoidance in clinical trials of breast cancer.
Mañes-Sevilla M; Romero-Jiménez R; Herranz-Alonso A; Sánchez-Fresneda M; Gonzalez-Haba E; Collado-Borrel R; Benedi-González J; Sanjurjo-Sáez M
J Oncol Pharm Pract; 2019 Jul; 25(5):1099-1104. PubMed ID: 29792122
[TBL] [Abstract][Full Text] [Related]
6. Economic benefits of sponsored clinical trials on pharmaceutical expenditures at a medical center in Taiwan.
Shen LJ; Chou H; Huang CF; Chou GM; Chan WK; Wu FL
Contemp Clin Trials; 2011 Jul; 32(4):485-91. PubMed ID: 21530679
[TBL] [Abstract][Full Text] [Related]
7. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
8. Drug cost avoidance resulting from cancer clinical trials.
Bredin C; Eliasziw M; Syme R
Contemp Clin Trials; 2010 Nov; 31(6):524-9. PubMed ID: 20840876
[TBL] [Abstract][Full Text] [Related]
9. Cost-evaluation model for clinical trials in a hospital pharmacy service.
Idoate A; Ortega A; Carrera FJ; Aldaz A; Giráldez J
Pharm World Sci; 1995 Sep; 17(5):172-6. PubMed ID: 8574214
[TBL] [Abstract][Full Text] [Related]
10. Establishing a fee for handling investigational drug studies.
Ngu BQ; Schneider PJ; Kilarski DJ
Am J Hosp Pharm; 1982 Aug; 39(8):1308-10. PubMed ID: 7124750
[TBL] [Abstract][Full Text] [Related]
11. The need to consider the cost factor of drugs in clinical trials.
Reidenberg JW
Clin Pharmacol Ther; 2003 May; 73(5):477-8. PubMed ID: 12732849
[No Abstract] [Full Text] [Related]
12. [Approximation to the cost of pharmacological treatment of rheumatoid arthritis in Spain].
Mera Varela A; Blanco Rodríguez J; Caamaño Freire M
An Med Interna; 2003 Mar; 20(3):114-21. PubMed ID: 12756895
[TBL] [Abstract][Full Text] [Related]
13. The financial impact of investigational drug services.
Rogers SD; Lampasona V; Buchanan EC
Top Hosp Pharm Manage; 1994 Apr; 14(1):60-6. PubMed ID: 10133561
[TBL] [Abstract][Full Text] [Related]
14. A Time-Trend Economic Analysis of Cancer Drug Trials.
Cressman S; Browman GP; Hoch JS; Kovacic L; Peacock SJ
Oncologist; 2015 Jul; 20(7):729-36. PubMed ID: 26032135
[TBL] [Abstract][Full Text] [Related]
15. Economic benefits of investigational drug services at an academic institution.
LaFleur J; Tyler LS; Sharma RR
Am J Health Syst Pharm; 2004 Jan; 61(1):27-32. PubMed ID: 14725117
[TBL] [Abstract][Full Text] [Related]
16. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit.
Miyagawa CI; Rivera JO
Am J Hosp Pharm; 1986 Dec; 43(12):3008-13. PubMed ID: 3812508
[TBL] [Abstract][Full Text] [Related]
17. The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia.
Kobelt G; Spångberg A; Mattiasson A
BJU Int; 2004 Mar; 93(4):543-8. PubMed ID: 15008726
[TBL] [Abstract][Full Text] [Related]
18. The pharmacoeconomics of high-cost biotechnology products.
Dana WJ; Farthing K
Pharm Pract Manag Q; 1998 Jul; 18(2):23-31. PubMed ID: 10185236
[TBL] [Abstract][Full Text] [Related]
19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
20. Cost of medication-related problems at a university hospital.
Schneider PJ; Gift MG; Lee YP; Rothermich EA; Sill BE
Am J Health Syst Pharm; 1995 Nov; 52(21):2415-8. PubMed ID: 8564605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
